For Racing Regulators, Salix Debate Just Beginning
Tom LaMarra
June 27, 2012
Racing regulators around the country discuss Kentucky’s move to ban race-day furosemide administration.
Racing regulators around the country discuss Kentucky’s move to ban race-day furosemide administration.
A panel will present radiographic images of joints and endoscopic videos of throats Thoroughbred yearlings.
The medication furosemide (Salix) will be discussed by J. David Richardson, MD, and Foster Northrop, DVM.
Nearly 380 people posted photos of their purple pedicures to bring the total donation to $7,520.
The TRA has endorsed a policy for equine medication reform supported by many industry stakeholders.
Sophie Stenbeck has contributed $74,000 to provide veterinary care for the organization’s horses.
His owners elected euthanasia after the colt began showing laminitis signs in one of his uninjured legs.
Regulatory veterinarians implemented new protocol after an increase in the number of racing injuries in May.
The International Federation of Horseracing Authorities and the Hong Konj Jockey club support the decision.
The CHRB handed down the suspension after a horse in O’Neill’s care was found to have an elevated TCO2 level.
Kentucky horsemen, after the vote, said they intend to lobby lawmakers to oppose the regulation.
Two New York senators announced June 12 that they do not support a ban on race-day Salix administration.
The statistics-based system would notify track officials and regulatory vets if a horse is deemed at-risk.
The measure would ban the use of furosemide on race-day in graded and listed stakes over a three-year period.
The coalition is working to improve the health and safety of equines and humans at racetracks in the state.
The request for review came from Penny Chenery, Secretariat’s owner, and the Maryland Jockey Club’s president.
Stay on top of the most recent Horse Health news with
